Kasturba medical college to monitor adverse drug reaction
The department of pharmacology in the Kasturba medical college (KMC) has officially been declared the centre of monitoring adverse drug reaction. The decision has been taken by the Union ministry of health and family welfare under National Pharmacovigilance Programme.Under the new scheme of things, KMC will work towards raiding awareness about adverse drug reactions in coordination with...
Login or Register to read the full article
The department of pharmacology in the Kasturba medical college (KMC) has officially been declared the centre of monitoring adverse drug reaction. The decision has been taken by the Union ministry of health and family welfare under National Pharmacovigilance Programme.
Under the new scheme of things, KMC will work towards raiding awareness about adverse drug reactions in coordination with Professor Dr K L Bairy, professor. This initiative has been taken to promote the interests of patient's safety, and encouraging people to come and report such an incidence.
The government is working towards a single-focused effort to safeguard the health of people who suffer from sub-standard drugs, or effective use of medicines. Counterfeiting, antimicrobial resistance are few challenges faced by the the pharmaco-vigilance. If anyone finds any adverse effects of drugs, they may call toll free number and share your opinion with: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Sector 23, Raj Nagar, Ghaziabad. 201002. Toll free number 1800-180-3024 (9am-5.30pm weekdays).
Pharmacovigilance Program of India is handling the task of adverse Drug Reactions. Such episodes are reported from all over India to National Co-ordinating Centre housed at Indian Pharmacopoeia Commission, Ghaziabad. It works in collaboration with global ADR monitoring centre, Sweden to contribute to global ADRs data base. NCC-PvPI monitors ADRs among Indians and helps regulators take decision for safe use of medicines.
The purpose of the PvPI is to collate data, analyze it and use the inferences to recommend informed regulatory interventions, besides communicating risks to healthcare professionals and the public. The broadened patient safety scope of pharmaco-vigilance includes the detection of medicines of substandard quality as well as dispensing and administration errors, as confirmed by TOI.
Under the new scheme of things, KMC will work towards raiding awareness about adverse drug reactions in coordination with Professor Dr K L Bairy, professor. This initiative has been taken to promote the interests of patient's safety, and encouraging people to come and report such an incidence.
The government is working towards a single-focused effort to safeguard the health of people who suffer from sub-standard drugs, or effective use of medicines. Counterfeiting, antimicrobial resistance are few challenges faced by the the pharmaco-vigilance. If anyone finds any adverse effects of drugs, they may call toll free number and share your opinion with: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Sector 23, Raj Nagar, Ghaziabad. 201002. Toll free number 1800-180-3024 (9am-5.30pm weekdays).
Pharmacovigilance Program of India is handling the task of adverse Drug Reactions. Such episodes are reported from all over India to National Co-ordinating Centre housed at Indian Pharmacopoeia Commission, Ghaziabad. It works in collaboration with global ADR monitoring centre, Sweden to contribute to global ADRs data base. NCC-PvPI monitors ADRs among Indians and helps regulators take decision for safe use of medicines.
The purpose of the PvPI is to collate data, analyze it and use the inferences to recommend informed regulatory interventions, besides communicating risks to healthcare professionals and the public. The broadened patient safety scope of pharmaco-vigilance includes the detection of medicines of substandard quality as well as dispensing and administration errors, as confirmed by TOI.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd